Showing results (51-60 of 122) with videos related to
Sort By:
Pageof 13
Thrombosis and Haemostasis|December 5, 2021
Predictive Modeling Identifies Total Bleeds at 12-Weeks Postswitch to N8-GP Prophylaxis as a Predictor of Treatment ResponsePratima Chowdary, Kingsley Hampton, Victor Jiménez-Yuste, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2025
Qualification Criteria of Gene Therapy for Haemophilia-Opinion of the EAHAD Gene Therapy Working GroupWolfgang Miesbach, Ana Boban, Pratima Chowdary, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2019
Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation guidelineElaine Gray, Steve Kitchen, Annette Bowyer, et al.Hepatology Communications|April 13, 2019
Prothrombin Complex Concentrates for Coagulopathy in Liver Disease: Single-Center, Clinical Experience in 105 PatientsAnja Drebes, Marie de Vos, Sunita Gill, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|March 13, 2022
Laboratory coagulation tests and recombinant porcine factor VIII: A United Kingdom Haemophilia Centre Doctors' Organisation guidelineAnnette Bowyer, Elaine Gray, Anna Lowe, et al.Journal of Hepatology|June 28, 2012
Evaluation of coagulation abnormalities in acute liver failureBanwari Agarwal, Gavin Wright, Alex Gatt, et al.Journal of Thrombosis and Haemostasis : JTH|December 24, 2023
FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimeticSteven R Lentz, Pratima Chowdary, Lidia Gil, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|September 23, 2021
Delivery of AAV-based gene therapy through haemophilia centres-A need for re-evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHCWolfgang Miesbach, Pratima Chowdary, Michiel Coppens, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2020
Long-term safety and efficacy results from the phase 3b, open-label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated patients with severe haemophilia APratima Chowdary, Eric S Mullins, Barbara A Konkle, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|December 21, 2019
Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guidelineP Vincent Jenkins, Annette Bowyer, Clive Burgess, et al.Pageof 13